Investigation of the Efficacy and Safety of Drotrecogin Alfa (Activated) in Pediatric Severe Sepsis

This study has been completed.

Study NCT00049764 Information provided by Eli Lilly and Company

First Received: November 13, 2002 Last Updated: November 15, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2005
Estimated Primary Completion Date:	No date given